Pictet-Biotech I dy GBP (FUND:B554RF5) - Fund price


Fund Report

Pictet-Biotech I dy GBP

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Size
Share Class Size (mil)15.34 GBP
(13/07/2020)
Fund Size (mil)1,989.76 USD
(13/07/2020)
Mkt Cap % 30/06/2020
FundCat
Giant5.246.64
Large33.3627.59
Medium33.5837.04
Small26.2325.93
Micro1.602.79
Valuations and Growth Rates 30/06/2020
FundCategory
Price / Earnings20.9222.63
Price/Book4.975.07
Price/Sales5.367.42
Price/Cash Flow14.4417.74
Dividend-Yield Factor0.360.35
Long-Term Projected Earnings Growth11.9015.60
Historical Earnings Growth24.9626.36
Sales Growth17.0111.46
Cash-Flow Growth20.6712.45
Book-Value Growth15.8810.48

Asset Allocation % 30/06/2020

Asset Allocation
LongShortNetCat
Stocks97.290.0097.2995.03
Bonds0.500.200.300.02
Cash4.432.022.411.45
Other0.000.000.003.50
World Regions % 30/06/2020
FundCategory
Greater Europe2.268.89
United Kingdom0.971.80
Eurozone0.374.22
Europe - ex Euro0.912.85
Europe - Emerging0.000.00
Africa0.000.00
Middle East0.000.01
Americas96.2086.38
United States94.0185.33
Canada2.191.05
Latin America0.000.00
Greater Asia1.554.73
Japan0.001.20
Australasia0.000.12
Asia - Developed0.000.29
Asia - Emerging1.553.11
Stock Sector Weightings % 30/06/2020
FundCategory
Cyclical0.000.25
Basic Materials--
Consumer Cyclical--
Financial Services-0.25
Real Estate--
Sensitive0.000.84
Communication Services--
Energy--
Industrials-0.23
Technology-0.61
Defensive100.0098.91
Consumer Defensive--
Healthcare100.0098.91
Utilities--

Top 10 Holdings30/06/2020

Assets in Top 10 Holdings %46.50
Total Number of Equity Holdings54
Total Number of Bond Holdings46
NameSectorCountry%
IncreaseDecreaseNew since last portfolio
DecreaseVertex Pharmaceuticals Inc HealthcareUnited States6.30
IncreaseBiomarin Pharmaceutical Inc HealthcareUnited States5.43
DecreaseAmgen Inc HealthcareUnited States5.09
IncreaseGilead Sciences Inc HealthcareUnited States4.78
IncreaseAlexion Pharmaceuticals Inc HealthcareUnited States4.73
DecreaseRegeneron Pharmaceuticals Inc HealthcareUnited States4.69
IncreaseSeattle Genetics Inc HealthcareUnited States4.52
IncreaseExelixis Inc HealthcareUnited States3.97
DecreaseIncyte Corp HealthcareUnited States3.68
IncreaseNeurocrine Biosciences Inc HealthcareUnited States3.31
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.